BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33586998)

  • 1. Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
    Kowa JY; Soneji N; Sohaib SA; Mayer E; Hazell S; Butterfield N; Shur J; Ap Dafydd D
    Br J Radiol; 2021 Apr; 94(1120):20201423. PubMed ID: 33586998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI Tumor Probability Model for the Detection of Locally Recurrent Prostate Cancer After Radiation Therapy: Pathologic Validation and Comparison With Manual Tumor Delineations.
    Dinis Fernandes C; Simões R; Ghobadi G; Heijmink SWTPJ; Schoots IG; de Jong J; Walraven I; van der Poel HG; van Houdt PJ; Smolic M; Pos FJ; van der Heide UA
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):140-148. PubMed ID: 31085288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of multiparametric mri in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy.
    Faiella E; Santucci D; Vertulli D; Esperto F; Messina L; Castiello G; Papalia R; Flammia G; Scarpa RM; Fiore M; Trodella LE; Ramella S; Grasso RF; Beomonte Zobel B
    Actas Urol Esp (Engl Ed); 2022 Sep; 46(7):397-406. PubMed ID: 35778338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer.
    Breen WG; Stish BJ; Harmsen WS; Froemming AT; Mynderse LA; Choo CR; Davis BJ; Pisansky TM
    Radiother Oncol; 2021 Aug; 161():9-15. PubMed ID: 34023327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response on DCE-MRI predicts outcome of salvage radiotherapy for local recurrence after radical prostatectomy.
    Sanguineti G; Bertini L; Faiella A; Ferriero MC; Marzi S; Farneti A; Landoni V
    Tumori; 2021 Feb; 107(1):55-63. PubMed ID: 32180511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
    Light A; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Emara A; Haroon A; Latifoltojar A; Sidhu H; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra AV; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU; Shah TT
    Eur Urol; 2024 Jan; 85(1):35-46. PubMed ID: 37778954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
    Venkatesan AM; Mudairu-Dawodu E; Duran C; Stafford RJ; Yan Y; Wei W; Kundra V
    Cancer Imaging; 2021 Jan; 21(1):3. PubMed ID: 33407861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
    Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
    Shah TT; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Grierson J; Miah H; Emara A; Haroon A; Latifoltojar A; Sidhu H; Clemente J; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra A; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU
    Eur Urol; 2022 Jun; 81(6):598-605. PubMed ID: 35370021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
    Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
    Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of
    García JR; Compte A; Buxeda M; Mourelo S; Soler M; Blanch A; Valls E; Riera E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):197-203. PubMed ID: 32165153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study.
    Bosaily AE; Frangou E; Ahmed HU; Emberton M; Punwani S; Kaplan R; Brown LC; Freeman A; Jameson C; Hindley R; Peppercorn D; Thrower A; Winkler M; Barwick T; Stewart V; Burns-Cox N; Burn P; Ghei M; Kumaradevan J; Prasad R; Ash-Miles J; Shergill I; Agarwal S; Rosario D; Salim F; Bott S; Evans H; Henderson A; Ghosh S; Dudderidge T; Smart J; Tung K; Kirkham A;
    Eur Urol; 2020 Oct; 78(4):503-511. PubMed ID: 32312543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil.
    Rischke HC; Schäfer AO; Nestle U; Volegova-Neher N; Henne K; Benz MR; Schultze-Seemann W; Langer M; Grosu AL
    Radiat Oncol; 2012 Oct; 7():185. PubMed ID: 23114282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
    Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
    Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of CE-MRI in detecting local recurrence after radical prostatectomy.
    Coppola A; Platania G; Ticca C; De Mattia C; Bortolato B; Palazzi MF; Vanzulli A
    Radiol Med; 2020 Jul; 125(7):683-690. PubMed ID: 32078119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging for the Detection of Locoregional Recurrences in Biochemical Progression After Radical Prostatectomy-A Systematic Review.
    Sandgren K; Westerlinck P; Jonsson JH; Blomqvist L; Thellenberg Karlsson C; Nyholm T; Dirix P
    Eur Urol Focus; 2019 Jul; 5(4):550-560. PubMed ID: 29133278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomy.
    Parra NA; Orman A; Padgett K; Casillas V; Punnen S; Abramowitz M; Pollack A; Stoyanova R
    Strahlenther Onkol; 2017 Jan; 193(1):13-21. PubMed ID: 27761612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.